OKTA vs PRCT · P/E 84, rev $1.57B vs rev $177.6M
Okta Inc (OKTA) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported PRCT revenue for 2026-06-30 was $177.6M. Net income was -$58.5M. PRCT currently screens at market cap $1.52B.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the OKTA and PRCT stock pages for the full models.
Not investment advice.